These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 18330979)

  • 1. Glycosylation site-specific analysis of HIV envelope proteins (JR-FL and CON-S) reveals major differences in glycosylation site occupancy, glycoform profiles, and antigenic epitopes' accessibility.
    Go EP; Irungu J; Zhang Y; Dalpathado DS; Liao HX; Sutherland LL; Alam SM; Haynes BF; Desaire H
    J Proteome Res; 2008 Apr; 7(4):1660-74. PubMed ID: 18330979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glycosylation site-specific analysis of clade C HIV-1 envelope proteins.
    Go EP; Chang Q; Liao HX; Sutherland LL; Alam SM; Haynes BF; Desaire H
    J Proteome Res; 2009 Sep; 8(9):4231-42. PubMed ID: 19610667
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycosylation Benchmark Profile for HIV-1 Envelope Glycoprotein Production Based on Eleven Env Trimers.
    Go EP; Ding H; Zhang S; Ringe RP; Nicely N; Hua D; Steinbock RT; Golabek M; Alin J; Alam SM; Cupo A; Haynes BF; Kappes JC; Moore JP; Sodroski JG; Desaire H
    J Virol; 2017 May; 91(9):. PubMed ID: 28202756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of HPLC/ESI-FTICR MS versus MALDI-TOF/TOF MS for glycopeptide analysis of a highly glycosylated HIV envelope glycoprotein.
    Irungu J; Go EP; Zhang Y; Dalpathado DS; Liao HX; Haynes BF; Desaire H
    J Am Soc Mass Spectrom; 2008 Aug; 19(8):1209-20. PubMed ID: 18565761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Changes in Structure and Antigenicity of HIV-1 Env Trimers Resulting from Removal of a Conserved CD4 Binding Site-Proximal Glycan.
    Liang Y; Guttman M; Williams JA; Verkerke H; Alvarado D; Hu SL; Lee KK
    J Virol; 2016 Oct; 90(20):9224-36. PubMed ID: 27489265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glycosylation and disulfide bond analysis of transiently and stably expressed clade C HIV-1 gp140 trimers in 293T cells identifies disulfide heterogeneity present in both proteins and differences in O-linked glycosylation.
    Go EP; Hua D; Desaire H
    J Proteome Res; 2014 Sep; 13(9):4012-27. PubMed ID: 25026075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antigenicity and immunogenicity of HIV-1 consensus subtype B envelope glycoproteins.
    Kothe DL; Decker JM; Li Y; Weng Z; Bibollet-Ruche F; Zammit KP; Salazar MG; Chen Y; Salazar-Gonzalez JF; Moldoveanu Z; Mestecky J; Gao F; Haynes BF; Shaw GM; Muldoon M; Korber BT; Hahn BH
    Virology; 2007 Mar; 360(1):218-34. PubMed ID: 17097711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific N-linked and O-linked glycosylation modifications in the envelope V1 domain of simian immunodeficiency virus variants that evolve in the host alter recognition by neutralizing antibodies.
    Chackerian B; Rudensey LM; Overbaugh J
    J Virol; 1997 Oct; 71(10):7719-27. PubMed ID: 9311856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Analysis of the Glycosylation Profiles of Membrane-Anchored HIV-1 Envelope Glycoprotein Trimers and Soluble gp140.
    Go EP; Herschhorn A; Gu C; Castillo-Menendez L; Zhang S; Mao Y; Chen H; Ding H; Wakefield JK; Hua D; Liao HX; Kappes JC; Sodroski J; Desaire H
    J Virol; 2015 Aug; 89(16):8245-57. PubMed ID: 26018173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycan profiles of the 27 N-glycosylation sites of the HIV envelope protein CN54gp140.
    Pabst M; Chang M; Stadlmann J; Altmann F
    Biol Chem; 2012 Aug; 393(8):719-30. PubMed ID: 22944675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid Induction of Multifunctional Antibodies in Rabbits and Macaques by Clade C HIV-1 CAP257 Envelopes Circulating During Epitope-Specific Neutralization Breadth Development.
    Malherbe DC; Wibmer CK; Nonyane M; Reed J; Sather DN; Spencer DA; Schuman JT; Guo B; Pandey S; Robins H; Park B; Fuller DH; Sacha JB; Moore PL; Hessell AJ; Haigwood NL
    Front Immunol; 2020; 11():984. PubMed ID: 32582155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycoform analysis of recombinant and human immunodeficiency virus envelope protein gp120 via higher energy collisional dissociation and spectral-aligning strategy.
    Yang W; Shah P; Toghi Eshghi S; Yang S; Sun S; Ao M; Rubin A; Jackson JB; Zhang H
    Anal Chem; 2014 Jul; 86(14):6959-67. PubMed ID: 24941220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A recombinant gp145 Env glycoprotein from HIV-1 expressed in two different cell lines: Effects on glycosylation and antigenicity.
    González-Feliciano JA; Akamine P; Capó-Vélez CM; Delgado-Vélez M; Dussupt V; Krebs SJ; Wojna V; Polonis VR; Baerga-Ortiz A; Lasalde-Dominicci JA
    PLoS One; 2020; 15(6):e0231679. PubMed ID: 32559193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosylation of the core of the HIV-1 envelope subunit protein gp120 is not required for native trimer formation or viral infectivity.
    Rathore U; Saha P; Kesavardhana S; Kumar AA; Datta R; Devanarayanan S; Das R; Mascola JR; Varadarajan R
    J Biol Chem; 2017 Jun; 292(24):10197-10219. PubMed ID: 28446609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycosylation profiling to evaluate glycoprotein immunogens against HIV-1.
    Behrens AJ; Struwe WB; Crispin M
    Expert Rev Proteomics; 2017 Oct; 14(10):881-890. PubMed ID: 28870097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene editing in CHO cells to prevent proteolysis and enhance glycosylation: Production of HIV envelope proteins as vaccine immunogens.
    Li SW; Wright M; Healey JF; Hutchinson JM; O'Rourke S; Mesa KA; Lollar P; Berman PW
    PLoS One; 2020; 15(5):e0233866. PubMed ID: 32470085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Murine Antibody Responses to Cleaved Soluble HIV-1 Envelope Trimers Are Highly Restricted in Specificity.
    Hu JK; Crampton JC; Cupo A; Ketas T; van Gils MJ; Sliepen K; de Taeye SW; Sok D; Ozorowski G; Deresa I; Stanfield R; Ward AB; Burton DR; Klasse PJ; Sanders RW; Moore JP; Crotty S
    J Virol; 2015 Oct; 89(20):10383-98. PubMed ID: 26246566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Live rubella vectors can express native HIV envelope glycoproteins targeted by broadly neutralizing antibodies and prime the immune response to an envelope protein boost.
    Virnik K; Nesti E; Dail C; Scanlan A; Medvedev A; Vassell R; McGuire AT; Stamatatos L; Berkower I
    Vaccine; 2018 Aug; 36(34):5166-5172. PubMed ID: 30037665
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification, characterization, and immunogenicity of a soluble trimeric envelope protein containing a partial deletion of the V2 loop derived from SF162, an R5-tropic human immunodeficiency virus type 1 isolate.
    Srivastava IK; Stamatatos L; Kan E; Vajdy M; Lian Y; Hilt S; Martin L; Vita C; Zhu P; Roux KH; Vojtech L; C Montefiori D; Donnelly J; Ulmer JB; Barnett SW
    J Virol; 2003 Oct; 77(20):11244-59. PubMed ID: 14512572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probing the Structure of the HIV-1 Envelope Trimer Using Aspartate Scanning Mutagenesis.
    Das R; Datta R; Varadarajan R
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.